{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:43Z","timestamp":1792787743585,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015758","name":"Novo Nordisk Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015758","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12325-024-03094-3","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T07:30:27Z","timestamp":1737185427000},"page":"1265-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Assessment of the Potential Clinical and Economic Impact of Weight Loss in the Adult Population with Obesity and Associated Comorbidities in Spain"],"prefix":"10.1007","volume":"42","author":[{"given":"Mar\u00eda Dolores","family":"Ballesteros-Pomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ened","family":"Rodr\u00edguez-Urgell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Sastre-Bel\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0558-890X","authenticated-orcid":false,"given":"Alberto","family":"Mart\u00edn-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Schnecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Seg\u00fa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Brosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Vilarrasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"issue":"5","key":"3094_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0025-7753(07)72531-9","volume":"128","author":"J Salas-Salvad\u00f3","year":"2007","unstructured":"Salas-Salvad\u00f3 J, Rubio MA, Barbany M, Moreno B. Consenso SEEDO 2007 para la evaluaci\u00f3n del sobrepeso y la obesidad y el establecimiento de criterios de intervenci\u00f3n terap\u00e9utica. Med Clin (Barc). 2007;128(5):184\u201396.","journal-title":"Med Clin (Barc)"},{"issue":"14","key":"3094_CR2","first-page":"767","volume":"13","author":"JG Vaamonde","year":"2020","unstructured":"Vaamonde JG, \u00c1lvarez-M\u00f3n MA. Obesity and overweight. Medicine (Spain). 2020;13(14):767\u201376.","journal-title":"Medicine (Spain)"},{"issue":"7","key":"3094_CR3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12551","volume":"18","author":"GA Bray","year":"2017","unstructured":"Bray GA, Kim KK, Wilding JPH. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715\u201323.","journal-title":"Obes Rev"},{"key":"3094_CR4","doi-asserted-by":"crossref","unstructured":"Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci [Internet]. 2019;20(9):2358. https:\/\/www.mdpi.com\/1422-0067\/20\/9\/2358","DOI":"10.3390\/ijms20092358"},{"issue":"9945","key":"3094_CR5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766\u201381.","journal-title":"Lancet"},{"key":"3094_CR6","unstructured":"WHO. Obesity [Internet]. 2021. https:\/\/www.who.int\/news-room\/facts-in-pictures\/detail\/6-facts-on-obesity"},{"key":"3094_CR7","unstructured":"World Obesity Day. No Title."},{"key":"3094_CR8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ypmed.2010.03.016","volume":"51","author":"C Li","year":"2010","unstructured":"Li C, Ford ES, Zhao G, Croft J, Balluz L, Mokdad A. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005\u20132006. Prev Med. 2010;51:18\u201323.","journal-title":"Prev Med"},{"issue":"16","key":"3094_CR9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","volume":"282","author":"A Must","year":"1999","unstructured":"Must A. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523.","journal-title":"JAMA"},{"issue":"2","key":"3094_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ene.13216","volume":"24","author":"A Rodr\u00edguez-Campello","year":"2017","unstructured":"Rodr\u00edguez-Campello A, Jim\u00e9nez-Conde J, Ois \u00c1, Cuadrado-Godia E, Giralt-Steinhauer E, Vivanco RM, et al. Sex-related differences in abdominal obesity impact on ischemic stroke risk. Eur J Neurol. 2017;24(2):397\u2013403.","journal-title":"Eur J Neurol"},{"issue":"7","key":"3094_CR11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","volume":"23","author":"MP Czech","year":"2017","unstructured":"Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804\u201314.","journal-title":"Nat Med"},{"issue":"1","key":"3094_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Investig. 2017;127(1):1\u20134.","journal-title":"J Clin Investig"},{"issue":"5","key":"3094_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.11124\/JBISRIR-2016-002725","volume":"14","author":"L Cooper","year":"2016","unstructured":"Cooper L, Ryan C, Ells LJ, Hamilton S, Atkinson G, Cooper K, et al. Weight-loss interventions for overweight\/obese adults with chronic musculoskeletal pain. JBI Database Syst Rev Implement Rep. 2016;14(5):57\u201367.","journal-title":"JBI Database Syst Rev Implement Rep"},{"issue":"4","key":"3094_CR14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, et al. Association of Body Mass Index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiol. 2018;3(4):280.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3094_CR15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"O Collaborators","year":"2017","unstructured":"Collaborators O. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13\u201327.","journal-title":"N Engl J Med"},{"issue":"6","key":"3094_CR16","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/s41366-021-00788-4","volume":"45","author":"CL Haase","year":"2021","unstructured":"Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes. 2021;45(6):1249\u201358.","journal-title":"Int J Obes"},{"issue":"2","key":"3094_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pcad.2018.06.004","volume":"61","author":"ME Pich\u00e9","year":"2018","unstructured":"Pich\u00e9 ME, Poirier P, Lemieux I, Despr\u00e9s JP. Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update. Prog Cardiovasc Dis. 2018;61(2):103\u201313.","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"3094_CR18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1467-789X.2010.00766.x","volume":"11","author":"A Sharma","year":"2010","unstructured":"Sharma A. M, M, M & M: a mnemonic for assessing obesity. Obes Rev. 2010;11(11):808\u20139.","journal-title":"Obes Rev"},{"issue":"1","key":"3094_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1471-2458-9-88","volume":"9","author":"DP Guh","year":"2009","unstructured":"Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9(1):88.","journal-title":"BMC Public Health"},{"issue":"3","key":"3094_CR20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","volume":"67","author":"FS Luppino","year":"2010","unstructured":"Luppino FS, Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Phenninx B, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010;67(3):220\u20139.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"3094_CR21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpsyc.63.7.824","volume":"63","author":"GE Simon","year":"2006","unstructured":"Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry. 2006;63(7):824.","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"3094_CR22","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1053\/j.gastro.2006.03.019","volume":"130","author":"TS Church","year":"2006","unstructured":"Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN. Association of cardiorespiratory fitness, body mass index, and waist circumference to non-alcoholic fatty liver disease. Gastroenterology. 2006;130(7):2023\u201330.","journal-title":"Gastroenterology"},{"issue":"2","key":"3094_CR23","first-page":"A48","volume":"6","author":"AS Hosler","year":"2009","unstructured":"Hosler AS. Prevalence of self-reported prediabetes among adults participating in a community-based health awareness program, New York State. Prev Chronic Dis. 2009;6(2):A48.","journal-title":"Prev Chronic Dis"},{"issue":"1","key":"3094_CR24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15277\/bjd.2019.205","volume":"19","author":"D Fountain","year":"2019","unstructured":"Fountain D, Al Kharaiji M, Awad S, Hughes D, Idris I. Prevalence of co-morbidities in a specialist weight management programme prior to bariatric surgery. Br J Diabetes. 2019;19(1):8\u201313.","journal-title":"Br J Diabetes"},{"key":"3094_CR25","unstructured":"Organisation for Economic Cooperation and Development (OECD). Heavy Burden of Obesity: The Economics of Prevention [Internet]. 2019 [cited 2022 Apr 1]. https:\/\/www.oecd.org\/health\/health-systems\/Heavy-burden-of-obesity-Policy-Brief-2019.pdf. Accessed 18 July 2024."},{"key":"3094_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","volume":"22","author":"WT Garvey","year":"2016","unstructured":"Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1\u2013203.","journal-title":"Endocr Pract"},{"key":"3094_CR27","doi-asserted-by":"crossref","unstructured":"The Look AHEAD Research Group, Gregg E, Jakicic J, Blackburn G, Bloomquist P, Bray G, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913\u201321.","DOI":"10.1016\/S2213-8587(16)30162-0"},{"issue":"10120","key":"3094_CR28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391(10120):541\u201351.","journal-title":"Lancet"},{"issue":"6","key":"3094_CR29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/HCO.0b013e32834b7fc4","volume":"26","author":"F Benraouane","year":"2011","unstructured":"Benraouane F, Litwin SE. Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol. 2011;26(6):555\u201361.","journal-title":"Curr Opin Cardiol"},{"issue":"17","key":"3094_CR30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.116.025629","volume":"135","author":"J Sundstr\u00f6m","year":"2017","unstructured":"Sundstr\u00f6m J, Bruze G, Ottosson J, Marcus C, N\u00e4slund I, Neovius M. Weight loss and heart failure. Circulation. 2017;135(17):1577\u201385.","journal-title":"Circulation"},{"issue":"8","key":"3094_CR31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/dc15-1081","volume":"38","author":"WT Cefalu","year":"2015","unstructured":"Cefalu WT, Bray GA, Home PD, Garvey WT, Klein S, Pi-Sunyer FX, et al. Advances in the science, treatment, and prevention of the disease of obesity: reflections from a diabetes care editors\u2019 expert forum. Diabetes Care. 2015;38(8):1567\u201382.","journal-title":"Diabetes Care"},{"issue":"4","key":"3094_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/00325481.2022.2051366","volume":"134","author":"DB Horn","year":"2022","unstructured":"Horn DB, Almandoz JP, Look M. What is clinically relevant weight loss for your patients and how can it be achieved? A narrative review. Postgrad Med. 2022;134(4):359\u201375.","journal-title":"Postgrad Med"},{"issue":"1","key":"3094_CR33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","volume":"315","author":"DW Kitzman","year":"2016","unstructured":"Kitzman DW, Brubaker P, Morgan T, Haykowsky M, Hundley G, Kraus WE, et al. Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction. JAMA. 2016;315(1):36.","journal-title":"JAMA"},{"issue":"1","key":"3094_CR34","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1093\/ajcn\/82.1.222S","volume":"82","author":"RR Wing","year":"2005","unstructured":"Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr. 2005;82(1):S222\u20135.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"3094_CR35","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34(7):1481\u20136.","journal-title":"Diabetes Care"},{"key":"3094_CR36","unstructured":"Khunti K, Schnecke V, Morgen CLHNMHL, Rathor N, Sommer KS, Morgen CS. Degree of weight loss and risk of obesity-related complications: a retrospective cohort study. In: 29th European Congress on Obesity 2022 (ECO 2022). Maastrich; 2022."},{"issue":"12","key":"3094_CR37","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1111\/dom.14538","volume":"23","author":"A Mariam","year":"2021","unstructured":"Mariam A, Miller-Atkins G, Pantalone KM, Iyer N, Misra-Hebert AD, Milinovich A, et al. Associations of weight loss with obesity-related comorbidities in a large integrated health system. Diabetes Obes Metab. 2021;23(12):2804\u201313.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"3094_CR38","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/oby.23371","volume":"30","author":"AA Tahrani","year":"2022","unstructured":"Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: a review. Obesity. 2022;30(4):802\u201340.","journal-title":"Obesity"},{"issue":"Suppl 1","key":"3094_CR39","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/2327-6924.12510","volume":"29","author":"SM Fruh","year":"2017","unstructured":"Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(Suppl 1):S3.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"4","key":"3094_CR40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","volume":"23","author":"F Magkos","year":"2016","unstructured":"Magkos F, Fraterrigo G, Yoshino J, Luecking C, Kirbach K, Kelly SC, et al. Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity. Cell Metab. 2016;23(4):591\u2013601.","journal-title":"Cell Metab"},{"key":"3094_CR41","doi-asserted-by":"crossref","unstructured":"Warkentin LM, Majumdar SR, Johnson JA, Agborsangaya CB, Rueda-Clausen CF, Sharma AM, et al. Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: two-year prospective cohort study. BMC Med. 2014;12(1).","DOI":"10.1186\/s12916-014-0175-5"},{"issue":"4","key":"3094_CR42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.amepre.2011.06.042","volume":"41","author":"C Mason","year":"2011","unstructured":"Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain C, et al. Dietary weight-loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med. 2011;41(4):366.","journal-title":"Am J Prev Med"},{"issue":"2","key":"3094_CR43","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","volume":"369","author":"The Look AHEAD Research Group","year":"2013","unstructured":"The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145\u201354.","journal-title":"N Engl J Med"},{"issue":"9","key":"3094_CR44","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/jcm9092904","volume":"9","author":"P Macek","year":"2020","unstructured":"Macek P, Terek-Derszniak M, Biskup M, Krol H, Smok-Kalwat J, Gozdz S, et al. A two-year follow-up cohort study\u2014improved clinical control over CVD risk factors through weight loss in middle-aged and older adults. J Clin Med. 2020;9(9):2904.","journal-title":"J Clin Med"},{"key":"3094_CR45","unstructured":"Rethink Obesity. Obesity risk calculator [Internet]. https:\/\/www.rethinkobesity.global\/%0Aglobal\/en\/weight-and-health\/a-chronic-disease-thehealth-%0Aimpacts-of-obesity\/obesity-risk-calculator.%0Ahtml."},{"key":"3094_CR46","unstructured":"Organization for Economic Cooperation and Development (OECD). Obesity Update (2017) [Internet]. 2017. https:\/\/www.oecd.org\/els\/health-systems\/Obesity-Update-2017.pdf"},{"issue":"3","key":"3094_CR47","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.recesp.2020.12.013","volume":"75","author":"C P\u00e9rez-Rodrigo","year":"2022","unstructured":"P\u00e9rez-Rodrigo C, Herv\u00e1s B\u00e1rbara G, Gianzo Citores M, Aranceta-Bartrina J. Prevalencia de obesidad y factores de riesgo cardiovascular asociados en la poblaci\u00f3n general espa\u00f1ola: Estudio ENPE. Rev Esp Cardiol. 2022;75(3):232\u201341.","journal-title":"Rev Esp Cardiol"},{"key":"3094_CR48","unstructured":"WOF. World Obesity Atlas 2024. 2024; https:\/\/data.worldobesity.org\/publications\/?cat=22"},{"issue":"11","key":"3094_CR49","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.rec.2018.10.010","volume":"72","author":"\u00c1 Hern\u00e1ez","year":"2019","unstructured":"Hern\u00e1ez \u00c1, Zome\u00f1o MD, D\u00e9gano IR, P\u00e9rez-Fern\u00e1ndez S, Goday A, Vila J, et al. Excess weight in Spain: current situation, projections for 2030, and estimated direct extra cost for the Spanish Health System. Rev Esp Cardiol. 2019;72(11):916\u201324. https:\/\/doi.org\/10.1016\/j.rec.2018.10.010","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"3094_CR50","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s12325-022-02415-8","volume":"40","author":"SA Alqahtani","year":"2023","unstructured":"Alqahtani SA, Al-Omar HA, Alshehri A, Abanumay A, Alabdulkarim H, Alrumaih A, et al. Obesity burden and impact of weight loss in Saudi Arabia: a modelling study. Adv Ther. 2023;40(3):1114\u201328.","journal-title":"Adv Ther"},{"key":"3094_CR51","unstructured":"INE. Instituto Nacional de Estad\u00edstica. Cifras de poblaci\u00f3n y censos demogr\u00e1ficos. Proyecciones de poblaci\u00f3n. [Internet]. 2021. https:\/\/www.ine.es\/"},{"key":"3094_CR52","unstructured":"eurostat. EHIS [Internet]. Body mass index (BMI) by level of disability (activity limitation), sex and age. https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/HLTH_EHIS_BM1D__custom_11972376\/default\/table?lang=en"},{"key":"3094_CR53","unstructured":"Ministerio de Sanidad. Encuesta Nacional de Salud 2017. 2017."},{"issue":"11","key":"3094_CR54","first-page":"485","volume":"142","author":"R Gomis","year":"2014","unstructured":"Gomis R, Artola S, Conthe P, Vidal J, Casamor R, Font B. Prevalencia de diabetes mellitus tipo 2 en pacientes ambulatorios con sobrepeso u obesidad en Espa\u00f1a. Estudio OBEDIA Med Clin. 2014;142(11):485\u201392.","journal-title":"Estudio OBEDIA Med Clin"},{"key":"3094_CR55","doi-asserted-by":"crossref","unstructured":"Soriguer F, Goday A, Bosch-Comas A, Bordi\u00fa E, Calle-Pascual A, Carmena R, et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012;55(1):88\u201393.","DOI":"10.1007\/s00125-011-2336-9"},{"issue":"9","key":"3094_CR56","volume":"8","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhang XPXY, Yuan J, Cai B, Wang XL, Wu XL, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ Open. 2018;8(9): e021768.","journal-title":"BMJ Open"},{"key":"3094_CR57","unstructured":"Gisbert R, Brosa M. Base de datos de costes sanitarios espa\u00f1oles: eSalud [Internet]. 2024 [cited 2024 Apr 5]. http:\/\/www.oblikue.com\/bddcostes\/"},{"key":"3094_CR58","unstructured":"Instituto Nacional de Estad\u00edstica (INE). \u00cdndice de precios de consumo [Internet]. 2024 [cited 2024 Apr 15]. https:\/\/www.ine.es\/calcula\/"},{"issue":"9","key":"3094_CR59","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1111\/dom.15154","volume":"25","author":"KKF MedSci","year":"2023","unstructured":"MedSci KKF, Schnecke V, Haase CL, Harder-Lauridsen NM, Rathor N, Sommer K, et al. Weight change and risk of obesity-related complications: a retrospective population-based cohort study of a UK primary care database. Diabetes Obes Metab. 2023;25(9):2669\u201379.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"3094_CR60","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0197-2456(03)00064-3","volume":"24","author":"The Look AHEAD Research Group","year":"2003","unstructured":"The Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610\u201328.","journal-title":"Control Clin Trials"},{"issue":"6","key":"3094_CR61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","volume":"8","author":"S Taheri","year":"2020","unstructured":"Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):477\u201389.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"3094_CR62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5534\/wjmh.200010","volume":"39","author":"YJ Tak","year":"2021","unstructured":"Tak YJ, Lee SY. Anti-obesity drugs: long-term efficacy and safety: an updated review. World J Mens Health. 2021;39(2):208.","journal-title":"World J Mens Health"},{"issue":"3","key":"3094_CR63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","volume":"387","author":"AM Jastreboff","year":"2022","unstructured":"Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205\u201316.","journal-title":"N Engl J Med"},{"issue":"14","key":"3094_CR64","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","volume":"325","author":"D Rubino","year":"2021","unstructured":"Rubino D, Abrahamsson N, Davies M, Hesse D, Greenway FL, Jensen C, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA. 2021;325(14):1414.","journal-title":"JAMA"},{"issue":"1","key":"3094_CR65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"3","key":"3094_CR66","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.281.3.235","volume":"281","author":"MH Davidson","year":"1999","unstructured":"Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA. 1999;281(3):235.","journal-title":"JAMA"},{"issue":"10","key":"3094_CR67","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s11695-017-2866-4","volume":"27","author":"B Sheng","year":"2017","unstructured":"Sheng B, Truong K, Spitler H, Zhang L, Tong X, Chen L. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg. 2017;27(10):2724\u201332.","journal-title":"Obes Surg"},{"issue":"4","key":"3094_CR68","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2337\/dc15-1407","volume":"39","author":"K Sj\u00f6holm","year":"2016","unstructured":"Sj\u00f6holm K, Sj\u00f6str\u00f6m E, Carlsson LMS, Peltonen M. Weight change-adjusted effects of gastric bypass surgery on glucose metabolism: 2- and 10-year results from the Swedish Obese Subjects (SOS) Study. Diabetes Care. 2016;39(4):625\u201331.","journal-title":"Diabetes Care"},{"issue":"3","key":"3094_CR69","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s11695-018-3593-1","volume":"29","author":"R Welbourn","year":"2019","unstructured":"Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J, et al. Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the fourth IFSO Global Registry Report 2018. Obes Surg. 2019;29(3):782\u201395.","journal-title":"Obes Surg"},{"issue":"10322","key":"3094_CR70","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, Sumithran P, Cohen RV, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399(10322):394\u2013405.","journal-title":"Lancet"},{"issue":"23","key":"3094_CR71","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.284.23.3015","volume":"284","author":"PE Peppard","year":"2000","unstructured":"Peppard PE. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015.","journal-title":"JAMA"},{"issue":"2","key":"3094_CR72","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10198-014-0562-z","volume":"16","author":"T Mora","year":"2015","unstructured":"Mora T, Gil J, Sicras-Mainar A. The influence of obesity and overweight on medical costs: a panel data perspective. Eur J Health Econ. 2015;16(2):161\u201373.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"3094_CR73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000547","volume":"2","author":"A Sicras-Mainar","year":"2012","unstructured":"Sicras-Mainar A, Gil J, Mora T, Navarro-Artieda R, Ayma J. Healthcare use and costs associated with obesity in Badalona, Spain: a study protocol: Table 1. BMJ Open. 2012;2(1): e000547.","journal-title":"BMJ Open"},{"key":"3094_CR74","unstructured":"Mackenbach JP. Health Inequalities: Europe in Profile [Internet]. 2006. https:\/\/ec.europa.eu\/health\/ph_determinants\/socio_economics\/documents\/ev_060302_rd06_en.pdf"},{"issue":"6","key":"3094_CR75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.avdiab.2013.07.007","volume":"29","author":"C Crespo","year":"2013","unstructured":"Crespo C, Brosa M, Soria-Juan A, Lopez-Alba A, L\u00f3pez-Mart\u00ednez N, Soria B. Costes directos de la diabetes mellitus y de sus complicaciones en Espa\u00f1a (Estudio SECCAID: Spain estimated cost Ciberdem-Cabimer in Diabetes). Av Diabetol. 2013;29(6):182\u20139.","journal-title":"Av Diabetol"},{"issue":"3","key":"3094_CR76","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ahj.2005.03.003","volume":"151","author":"G Foster","year":"2006","unstructured":"Foster G. The behavioral approach to treating obesity. Am Heart J. 2006;151(3):625\u20137.","journal-title":"Am Heart J"},{"key":"3094_CR77","volume":"14","author":"C Ma","year":"2017","unstructured":"Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ. 2017;14: j4849.","journal-title":"BMJ"},{"issue":"12","key":"3094_CR78","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.medcli.2013.04.047","volume":"142","author":"JJ Mart\u00edn-Ramiro","year":"2014","unstructured":"Mart\u00edn-Ramiro JJ, \u00c1lvarez-Mart\u00edn E, Gil-Prieto R. Mortalidad atribuible al exceso de peso en Espa\u00f1a. Med Clin (Barc). 2014;142(12):526\u201330.","journal-title":"Med Clin (Barc)"},{"issue":"2","key":"3094_CR79","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.endinu.2020.05.003","volume":"68","author":"MD Ballesteros Pomar","year":"2021","unstructured":"Ballesteros Pomar MD, Vilarrasa Garc\u00eda N, Rubio Herrera M\u00c1, Barahona MJ, Bueno M, Caix\u00e0s A, et al. Abordaje cl\u00ednico integral SEEN de la obesidad en la edad adulta: resumen ejecutivo. Endocrinol Diabetes Nutr [Internet]. 2021;68(2):130\u20136.","journal-title":"Endocrinol Diabetes Nutr [Internet]."},{"key":"3094_CR80","unstructured":"Lecube A, Azriel S, Barreiro E, Blay G, Carretero J, Ciudin A, et al. Gu\u00eda Espa\u00f1ola GIRO: gu\u00eda espa\u00f1ola del manejo integral y multidisciplinar de la obesidad en personas adultas, 2024. 2024."},{"issue":"1","key":"3094_CR81","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1186\/s12913-023-10376-z","volume":"23","author":"C Escobar","year":"2023","unstructured":"Escobar C, Palacios B, Gonzalez V, Guti\u00e9rrez M, Duong M, Chen H, et al. Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain. BMC Health Serv Res. 2023;23(1):1340.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"3094_CR82","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12913-021-06566-2","volume":"21","author":"C Escobar","year":"2021","unstructured":"Escobar C, Palacios B, Aranda U, Capel M, Sicras A, Sicras A, et al. Costs and healthcare utilisation of patients with chronic kidney disease in Spain. BMC Health Serv Res. 2021;21(1):536.","journal-title":"BMC Health Serv Res"},{"key":"3094_CR83","doi-asserted-by":"crossref","unstructured":"Barrios V, et al. The REALITY project: analysis of a national database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain. Presentado en: ESC Congress 2022. 2022;","DOI":"10.1093\/eurheartj\/ehac544.2861"},{"issue":"9","key":"3094_CR84","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1080\/03007995.2020.1793749","volume":"36","author":"S D\u00edaz-Cerezo","year":"2020","unstructured":"D\u00edaz-Cerezo S, Romera I, Sicras-Mainar A, L\u00f3pez-Simarro F, Dilla T, Artime E, et al. Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain. Curr Med Res Opin. 2020;36(9):1449\u201356.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"3094_CR85","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14737167.2020.1807943","volume":"21","author":"J Rejas-Gutierrez","year":"2021","unstructured":"Rejas-Gutierrez J, Llopart-Carles N, Garc\u00eda-L\u00f3pez S, Darb\u00e0 J. Disease burden on health care by pain severity and usual analgesic treatment in patients with symptomatic osteoarthritis: a Spanish nationwide health survey. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):711\u20139.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"3094_CR86","doi-asserted-by":"crossref","unstructured":"Masa JF, Mokhlesi B, Ben\u00edtez I, G\u00f3mez de Terreros Caro FJ, S\u00e1nchez-Quiroga M\u00c1, Romero A, et al. Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea. Thorax. 2020;75(6):459\u201367.","DOI":"10.1136\/thoraxjnl-2019-213622"},{"issue":"8","key":"3094_CR87","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10198-018-0961-7","volume":"19","author":"M Casajuana","year":"2018","unstructured":"Casajuana M, Giner-Soriano M, Roso-Llorach A, Vedia C, Violan C, Morros R. Annual costs attributed to atrial fibrillation management: cross-sectional study of primary healthcare electronic records. Eur J Health Econ. 2018;19(8):1129\u201336.","journal-title":"Eur J Health Econ"},{"issue":"7","key":"3094_CR88","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737167.2022.2108794","volume":"22","author":"J Darb\u00e0","year":"2022","unstructured":"Darb\u00e0 J, Mars\u00e0 A. Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care. Expert Rev Pharmacoecon Outcomes Res. 2022;22(7):1147\u201352.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"3094_CR89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.medcli.2010.01.038","volume":"136","author":"A Sicras Mainar","year":"2011","unstructured":"Sicras Mainar A, Galera Llorca J, Mu\u00f1oz Ort\u00ed G, Navarro AR. Influencia del cumplimiento asociado a la incidencia de eventos cardiovasculares y los costes en combinaciones a dosis fijas en el tratamiento de la hipertensi\u00f3n arterial. Med Clin (Barc). 2011;136(5):183\u201391.","journal-title":"Med Clin (Barc)"},{"issue":"10","key":"3094_CR90","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.arbres.2009.04.006","volume":"45","author":"E Mart\u00ednez-Morag\u00f3n","year":"2009","unstructured":"Mart\u00ednez-Morag\u00f3n E, Serra-Batll\u00e9s J, De Diego A, Palop M, Casan P, Rubio-Terr\u00e9s C, et al. Coste econ\u00f3mico del paciente asm\u00e1tico en Espa\u00f1a (estudio AsmaCost). Arch Bronconeumol. 2009;45(10):481\u20136.","journal-title":"Arch Bronconeumol"},{"issue":"8","key":"3094_CR91","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/02770903.2018.1499035","volume":"56","author":"C Melero Moreno","year":"2019","unstructured":"Melero Moreno C, Quirce S, Huerta A, Ur\u00eda E, Cuesta M. Economic impact of severe asthma in Spain: multicentre observational longitudinal study. J Asthma. 2019;56(8):861\u201371.","journal-title":"J Asthma"},{"issue":"5","key":"3094_CR92","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/13696998.2020.1719118","volume":"23","author":"A Sicras-Mainar","year":"2020","unstructured":"Sicras-Mainar A, Capel M, Navarro-Artieda R, Nuevo J, Orellana M, Resler G. Real-life retrospective observational study to determine the prevalence and economic burden of severe asthma in Spain. J Med Econ. 2020;23(5):492\u2013500.","journal-title":"J Med Econ"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03094-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-024-03094-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-024-03094-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:53:02Z","timestamp":1738407182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-024-03094-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1007\/s12325-024-03094-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and manuscript have been promoted by Novo Nordisk Pharma SA. Alberto Mart\u00edn-Lorenzo is an employee of Novo Nordisk Pharma SA and Volker Schnecke is an employee of Novo Nordisk A\/S. Llu\u00eds Seg\u00fa, Max Brosa, Ened Rodr\u00edguez-Urgell\u00e9s and Miquel Sastre-Bel\u00edo are employees in PharmaLex Spain, which have received a consulting fee from Novo Nordisk Pharma SA. Mar\u00eda Dolores Ballesteros-Pomar have recieved honoraria or consultancy services from Novo Nordisk Pharma SA, Lilly, Bohringer, Fresenius Kabi, Nutricia Danone, Nestl\u00e9 Healthcare, Vegenat and Abbott Nutrition. Nuria Vilarrasa have received honoraria for consultancy services from Novo Nordisk Pharma SA, Lilly, Boeringher-Ingelheim, Adventia Pharma and FAES Pharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The results presented in this manuscript are based on published studies. All procedures performed in those studies involving human participants were conducted in accordance with the ethical standards of the local Institutional Review Boards for each site and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in publication of these studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}